Eva Bøge serves as Senior Director, Regulatory Affairs at Hemab. She brings extensive experience in shaping development strategies for multiple therapeutic modalities including rare diseases. Her leadership spans the full lifecycle from early phase to submission of marketing authorization applications leading to approval. She has worked at both small and large organizations, including Lundbeck, Leo Pharma and most recently at Zealand Pharma, where she was Director, Regulatory Affairs. Eva holds a Master in Pharmacy and a Master of Industrial Drug Development, both from the University of Copenhagen, Denmark.